Daxor Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Daxor Corporation's estimated annual revenue is currently $3.5M per year. 0
Employee Data
- 00
Daxor Corporation's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President/CEO/Chief Scientific Officer | Reveal Email/Phone |
Daxor Corporation Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 3 | 0% | N/A | N/A |
#2 | N/A | 20 | 43% | N/A | N/A |
#3 | $6.7M | 33 | -6% | N/A | N/A |
#4 | $34.4M | 222 | -1% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $10M | N/A |
#6 | $2M | 13 | 0% | N/A | N/A |
#7 | $7.5M | 37 | 0% | $51.6M | N/A |
#8 | $0.3M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 21 | -16% | $3.3M | N/A |
#10 | $3.6M | 20 | 5% | N/A | N/A |
What Is Daxor Corporation?
Daxor manufactures and markets the BVA-100 a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. It is the first instrument to provide rapid direct measurement of a patient\'s blood volume. The BVA-100 enables physicians to have access to technology which allows them to obtain blood volume measurements rapidly and with a high degree of precision.
keywords:N/A
N/A
Total Funding
N/A
Number of Employees
$3.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Daxor Corporation News
Oak Ridge, TN, April 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology,...
Oak Ridge, TN, March 01, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology,...
The SBIR/STTR Matching Fund Grant Will Advance the Company’s Innovation and Commercialization Efforts, and Job Creation Oak Ridge, TN, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announced Launch Tennessee (Lau ...
NEW YORK, May 28, 2021 - Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that Michael Feldschuh, Daxor's President and Chief Executive Officer will present at the Summer Solstice - Best Ideas from the Buy Side Conference, which is being he ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $40.9M | 0 | N/A | $11.9M |
#2 | $48.8M | 0 | N/A | $31.6M |
#3 | $13.9M | 0 | N/A | $35M |
#4 | $22.4M | 0 | N/A | $3.7M |
#5 | $1850M | 0 | N/A | N/A |